Why Oregon’s Drug Decriminalization Failed

Keith Humphreys and Rob Bovett

America’s most radical experiment with drug decriminalization has ended, after more than three years of painful results. Oregon Governor Tina Kotek has pledged to sign legislation repealing the principal elements of the ballot initiative known as Measure 110: Possessing hard drugs is again a crime in Oregon, and courts will return to mandating treatment for offenders. Oregonians had supported Measure 110 with 59 percent of the vote in 2020, but three years later, polling showed that 64 percent wanted some or all of it repealed. Although the measure was touted by advocates as a racial-justice policy, support for its repeal was especially strong among African American and Hispanic Oregonians.

The key elements of Measure 110 were the removal of criminal penalties for possession of small amounts of drugs such as methamphetamine, heroin, cocaine, and fentanyl, and a sharper focus, instead, on reducing the harm that drugs cause to their users. More than $260 million were allocated to services such as naloxone distribution, employment and housing services, and voluntary treatment. The original campaign for the measure was well funded by multiple backers, most prominently the Drug Policy Alliance, based in New York. Supporters hoped that ending penalties—and reducing the associated stigma of drug use—would bring a range of benefits. Once drugs were decriminalized and destigmatized, the thinking went, those who wanted to continue using would be more willing to access harm-reduction services that helped them use in safer ways. Meanwhile, the many people who wanted to quit using drugs but had been too ashamed or fearful to seek treatment would do so. Advocates foresaw a surge of help-seeking, a reduction in drug-overdose deaths, fewer racial disparities in the health and criminal-justice systems, lower rates of incarceration, and safer neighborhoods for all.